Organ Biology
Online ISSN : 2188-0204
Print ISSN : 1340-5152
ISSN-L : 1340-5152
メチルプレドニゾロンコハク酸エステルナトリウムの先発医薬品と後発医薬品間のリンパ球増殖抑制効果の比較
笹原 浩康杉山 健太郎磯貝 和也塚口 真穂登外山 聡佐藤 博齋藤 和英中川 由紀高橋 公太平野 俊彦
著者情報
ジャーナル フリー

2012 年 19 巻 1 号 p. 103-106

詳細
抄録
Use of generic drugs is recommended because of their economic advantage. However, bland and generic drugs have never been compared from the view point of their pharmacological efficacy by lymphocyte immunosuppressant-sensitivity test(LIST)with 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide(MTT)assay procedure. In this study, we evaluated the pharmacological efficacy of the bland and its generic drugs of methylprednisolone sodium succinate by LIST using peripheral blood mono nuclear cells (PBMCs) obtained from one healthy volunteer. The results showed wide difference of 90% confidence interval between IC50 logarithmic value; however, there were no statistically significant difference in IC50 logarithmic values between these drugs. We concluded from these data that immunosuppressive pharmacological efficacy of these generic methylprednisolone sodium succinate was almost equivalent to that of the bland drug. However, further investigation is recommended to evaluate and confirm the pharmacological and economic advantage between bland and generic drugs by LIST.
著者関連情報
© 2012 日本臓器保存生物医学会
前の記事 次の記事
feedback
Top